Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INCYTE CORPINCY · Entity 3182 | EVP, GMAPPS | July 16, 2025 | July 17, 2025 |
| Whitehawk Therapeutics, Inc.WHWK · Entity 6074 | Director | September 09, 2026 | September 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INCYTE CORP
Report date July 16, 2025 · Filed July 17, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 40,540 |
Reported balance
After 2025-07-16 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-07-16 · Sale · Disposed 983 · Balance 40,540 F1: This includes an aggregate of 37,752 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. |
Filing footnotes · ownership attribution and instrument terms
F1: This includes an aggregate of 37,752 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.
Whitehawk Therapeutics, Inc.
Report date September 09, 2026 · Filed September 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.19 · Expires 2036-09-09 | Direct | 76,080 |
Reported balance
After 2026-09-09 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-09 · Grant · Acquired 76,080 · Balance 76,080 F1: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one thirty-sixth (1/36th) of the shares subject to the option shall vest on a monthly basis following the grant date on the same day of the month as the grant date (and if there is no corresponding day, on the last day of the month) such that all shares subject to the option shall be fully vested on the three year anniversary of the grant date. The grant date is September 9, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one thirty-sixth (1/36th) of the shares subject to the option shall vest on a monthly basis following the grant date on the same day of the month as the grant date (and if there is no corresponding day, on the last day of the month) such that all shares subject to the option shall be fully vested on the three year anniversary of the grant date. The grant date is September 9, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 09, 2026 Filed Sep 11, 2026 20:04 UTC | Whitehawk Therapeutics, Inc. WHWK · Entity 6074 | GrantStock Option (right to buy) · Derivative | 76,080 | $0.00 Strike: $4.19 | $0.00 |
DisclosureSEC source: 0001670000-26-000008 · form4-09112026_080943.xml · derivative · entry 1 Iyengar Vijay K · CIK 0001670000 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,080 Underlying: Common Stock · 76,080 shares Expires 2036-09-09 F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one thirty-sixth (1/36th) of the shares subject to the option shall vest on a monthly basis following the grant date on the same day of the month as the grant date (and if there is no corresponding day, on the last day of the month) such that all shares subject to the option shall be fully vested on the three year anniversary of the grant date. The grant date is September 9, 2026. Read SEC document |
| July 16, 2025 Filed Jul 17, 2025 20:05 UTC | INCYTE CORP INCY · Entity 3182 | SaleCommon Stock | 983 | $68.36 | $67,197.88 |
DisclosureSEC source: 0000879169-25-000092 · wk-form4_1752782723.xml · nonDerivative · entry 1 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,540 F1 · balance_after: This includes an aggregate of 37,752 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 20:02 UTC | INCYTE CORP INCY · Entity 3182 | GrantEmployee Stock Option (right to buy) · Derivative | 14,472 | $0.00 Strike: $68.25 | $0.00 |
DisclosureSEC source: 0000879169-25-000081 · wk-form4_1752696159.xml · derivative · entry 6 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,472 Underlying: Common Stock · 14,472 shares Expires 2035-07-14 F5 · derivative.exercise_date: The July 15, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 20:02 UTC | INCYTE CORP INCY · Entity 3182 | GrantPerformance Shares · Derivative | 16,077 | $0.00 | $0.00 |
DisclosureSEC source: 0000879169-25-000081 · wk-form4_1752696159.xml · derivative · entry 5 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,077 Underlying: Common Stock · 16,077 shares Expires 2028-07-15 F4 · derivative.exercise_price: Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer. F4 · derivative.exercise_date: Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 20:02 UTC | INCYTE CORP INCY · Entity 3182 | GrantCommon Stock | 6,430 | $0.00 | $0.00 |
DisclosureSEC source: 0000879169-25-000081 · wk-form4_1752696159.xml · nonDerivative · entry 4 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,523 F2 · shares: Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis. F3 · balance_after: Including the July 15, 2025 grant, this includes an aggregate of 37,752 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 20:02 UTC | INCYTE CORP INCY · Entity 3182 | Tax withholdingCommon Stock | 836 | $68.25 | $57,057.00 |
DisclosureSEC source: 0000879169-25-000081 · wk-form4_1752696159.xml · nonDerivative · entry 3 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,093 F1 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of RSUs or earned performance shares previously reported in Table I as common stock. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 20:02 UTC | INCYTE CORP INCY · Entity 3182 | SaleCommon Stock | 1,177 | $69.86 | $82,225.22 |
DisclosureSEC source: 0000879169-25-000081 · wk-form4_1752696159.xml · nonDerivative · entry 2 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,929 Read SEC document |
| July 14, 2025 Filed Jul 16, 2025 20:02 UTC | INCYTE CORP INCY · Entity 3182 | Tax withholdingCommon Stock | 595 | $69.98 | $41,638.10 |
DisclosureSEC source: 0000879169-25-000081 · wk-form4_1752696159.xml · nonDerivative · entry 1 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,106 F1 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of RSUs or earned performance shares previously reported in Table I as common stock. Read SEC document |
| July 03, 2025 Filed Jul 7, 2025 20:43 UTC | INCYTE CORP INCY · Entity 3182 | SaleCommon Stock | 5,935 | $68.15 | $404,470.25 |
DisclosureSEC source: 0000879169-25-000072 · wk-form4_1751921008.xml · nonDerivative · entry 3 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,701 F2 · balance_after: Includes an aggregate of 34,913 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. Read SEC document |
| July 03, 2025 Filed Jul 7, 2025 20:43 UTC | INCYTE CORP INCY · Entity 3182 | SaleCommon Stock | 2,682 | $68.16 | $182,805.12 |
DisclosureSEC source: 0000879169-25-000072 · wk-form4_1751921008.xml · nonDerivative · entry 2 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,636 Read SEC document |
| July 02, 2025 Filed Jul 7, 2025 20:43 UTC | INCYTE CORP INCY · Entity 3182 | Tax withholdingCommon Stock | 6,809 | $68.17 | $464,169.53 |
DisclosureSEC source: 0000879169-25-000072 · wk-form4_1751921008.xml · nonDerivative · entry 1 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 46,318 F1 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of RSUs or earned performance shares previously reported in Table I as common stock. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:52 UTC | INCYTE CORP INCY · Entity 3182 | GrantCommon Stock | 10,982 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-016581 · wk-form4_1743713528.xml · nonDerivative · entry 2 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,799 F2 · shares: Represents the shares of common stock underlying performance shares earned upon the achievement of performance criteria determined to be satisfied on April 1, 2025. The earned shares will vest on the third anniversary of the July 2, 2022 grant date, subject to the Reporting Persons continued service with the Issuer. Each performance share represents the right to receive one or more shares of common stock based on, and subject to, specified development, revenue and market-based (relative total shareholder returns compared to the Nasdaq Biotechnology Index) performance goals determined by the Issuers Compensation Committee in January 2022 as set forth in the Performance Share Award Agreement. The number of shares of common stock that the Reporting Person is entitled to receive over the three year performance period ranges from 0% to 150% of the number of performance shares awarded. F3 · balance_after: Includes an aggregate of 50,339 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:52 UTC | INCYTE CORP INCY · Entity 3182 | GrantCommon Stock | 11,159 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-016581 · wk-form4_1743713528.xml · nonDerivative · entry 1 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,817 F1 · shares: Represents shares of common stock underlying performance shares earned upon the achievement of performance criteria determined to be satisfied on April 1, 2025. The earned shares will vest on November 30, 2025, subject to the Reporting Persons continued service with the Issuer. Each performance share represents the right to receive one or more shares of common stock based on, and subject to, achievement of specified Opzelura performance goals. The number of shares of common stock that the Reporting Person is entitled to receive over the three year performance period ranges from 0% to 150% of the number of performance shares awarded. Read SEC document |
| January 17, 2025 Filed Jan 22, 2025 21:09 UTC | INCYTE CORP INCY · Entity 3182 | GrantEmployee Stock Option (right to buy) · Derivative | 14,772 | $0.00 Strike: $71.93 | $0.00 |
DisclosureSEC source: 0000879169-25-000040 · wk-form4_1737580167.xml · derivative · entry 1 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,772 Underlying: Common Stock · 14,772 shares Expires 2035-01-16 F1 · derivative.exercise_date: Beginning January 17, 2025, options become exercisable in 37 installments, with the first 25% vesting on July 15, 2025 and the remainder vesting monthly over three years. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 17:52 UTC | INCYTE CORP INCY · Entity 3182 | SaleCommon Stock | 5,683 | $75.37 | $428,327.71 |
DisclosureSEC source: 0000879169-24-000176 · wk-form4_1733248327.xml · nonDerivative · entry 2 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,658 F1 · balance_after: Includes an aggregate of 28,198 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 17:52 UTC | INCYTE CORP INCY · Entity 3182 | SaleCommon Stock | 360 | $75.60 | $27,216.00 |
DisclosureSEC source: 0000879169-24-000176 · wk-form4_1733248327.xml · nonDerivative · entry 1 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,341 Read SEC document |
| July 25, 2024 Filed Jul 29, 2024 19:50 UTC | INCYTE CORP INCY · Entity 3182 | SaleCommon Stock | 15,571 | $70.00 | $1,089,970.00 |
DisclosureSEC source: 0000879169-24-000143 · wk-form4_1722282621.xml · nonDerivative · entry 1 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,701 F1 · balance_after: This includes an aggregate of 28,198 shares of common stock issuable pursuant to previously report RSUs and earned performance shares that have not vested. Read SEC document |
| July 15, 2024 Filed Jul 17, 2024 16:26 UTC | INCYTE CORP INCY · Entity 3182 | GrantEmployee Stock Option (right to buy) · Derivative | 16,284 | $0.00 Strike: $64.25 | $0.00 |
DisclosureSEC source: 0000879169-24-000132 · wk-form4_1721233574.xml · derivative · entry 3 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,284 Underlying: Common Stock · 16,284 shares Expires 2034-07-14 F4 · derivative.exercise_date: The July 15, 2024 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Read SEC document |
| July 15, 2024 Filed Jul 17, 2024 16:26 UTC | INCYTE CORP INCY · Entity 3182 | Tax withholdingCommon Stock | 549 | $64.25 | $35,273.25 |
DisclosureSEC source: 0000879169-24-000132 · wk-form4_1721233574.xml · nonDerivative · entry 2 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,272 F2 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of RSUs or earned performance shares previously reported in Table I as common stock. F3 · balance_after: Including the July 15, 2024 grant, this includes an aggregate of 28,198 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. Read SEC document |
| July 15, 2024 Filed Jul 17, 2024 16:26 UTC | INCYTE CORP INCY · Entity 3182 | GrantCommon Stock | 7,278 | $0.00 | $0.00 |
DisclosureSEC source: 0000879169-24-000132 · wk-form4_1721233574.xml · nonDerivative · entry 1 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,821 F1 · shares: Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years, subject to the employee's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis. Read SEC document |
| July 02, 2024 Filed Jul 3, 2024 16:19 UTC | INCYTE CORP INCY · Entity 3182 | Tax withholdingCommon Stock | 5,706 | $59.02 | $336,768.12 |
DisclosureSEC source: 0000879169-24-000114 · wk-form4_1720023541.xml · nonDerivative · entry 1 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,543 F1 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of RSUs or earned performance shares previously reported in Table I as common stock. F2 · balance_after: Includes an aggregate of 22,692 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 17:48 UTC | INCYTE CORP INCY · Entity 3182 | GrantCommon Stock | 7,377 | $0.00 | $0.00 |
DisclosureSEC source: 0000879169-24-000056 · wk-form4_1708105693.xml · nonDerivative · entry 1 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,789 F1 · shares: Represents shares of common stock underlying performance shares earned upon the achievement of performance criteria determined to be satisfied on February 14, 2024. The earned shares will vest on the third anniversary of the July 2, 2021 grant date, subject to the Reporting Persons continued service with the Issuer. Each performance share represents the right to receive one or more shares of common stock based on, and subject to, the achievement of specified financial and development performance criteria determined by the Issuers Compensation Committee in January 2021 as set forth in the Performance Share Award Agreement. The number of shares of common stock that the Reporting Person is entitled to receive over the three year performance period ranges from 0% to 150% of the number of performance shares awarded. F2 · balance_after: Includes an aggregate of 38,533 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. Read SEC document |
| January 18, 2024 Filed Jan 22, 2024 18:02 UTC | INCYTE CORP INCY · Entity 3182 | GrantEmployee Stock Option (right to buy) · Derivative | 16,018 | $0.00 Strike: $61.18 | $0.00 |
DisclosureSEC source: 0000879169-24-000029 · wk-form4_1705946526.xml · derivative · entry 1 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,018 Underlying: Common Stock · 16,018 shares Expires 2034-01-17 F1 · derivative.exercise_date: Beginning January 18, 2024, options become exercisable in 37 installments, with the first 25% vesting on July 14, 2024 and the remainder vesting monthly over three years. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 18:05 UTC | INCYTE CORP INCY · Entity 3182 | SaleCommon Stock | 657 | $65.00 | $42,705.00 |
DisclosureSEC source: 0000879169-24-000006 · wk-form4_1704391505.xml · nonDerivative · entry 1 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,412 F1 · balance_after: Includes an aggregate of 31,156 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. Read SEC document |
| July 14, 2023 Filed Jul 18, 2023 20:00 UTC | INCYTE CORP INCY · Entity 3182 | GrantEmployee Stock Option (right to buy) · Derivative | 14,868 | $0.00 Strike: $61.76 | $0.00 |
DisclosureSEC source: 0001209191-23-042552 · doc4.xml · derivative · entry 2 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,868 Underlying: Common Stock · 14,868 shares Expires 2033-07-13 F3 · derivative.exercise_date: The July 14, 2023 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Read SEC document |
| July 14, 2023 Filed Jul 18, 2023 20:00 UTC | INCYTE CORP INCY · Entity 3182 | GrantCommon Stock | 7,089 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-042552 · doc4.xml · nonDerivative · entry 1 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,069 F1 · shares: Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years, subject to Vijay Iyengar's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis. F2 · balance_after: Including the July 14, 2023 RSU Grant, this includes an aggregate of 31,156 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not vested. Read SEC document |
| July 03, 2023 Filed Jul 6, 2023 20:00 UTC | INCYTE CORP INCY · Entity 3182 | Tax withholdingCommon Stock | 6,215 | $62.08 | $385,827.20 |
DisclosureSEC source: 0001209191-23-041506 · doc4.xml · nonDerivative · entry 1 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,980 F1 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of RSUs or earned performance shares previously reported in Table I as common stock. F2 · balance_after: This includes an aggregate of 24,067 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not vested. Read SEC document |
| January 26, 2023 Filed Jan 30, 2023 21:00 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $68.62 | $0.00 |
DisclosureSEC source: 0001209191-23-005452 · doc4.xml · derivative · entry 3 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,000 shares Expires 2028-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Beginning July 2, 2018, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2019 and the remainder vesting monthly over three years. Read SEC document |
| January 26, 2023 Filed Jan 30, 2023 21:00 UTC | INCYTE CORP INCY · Entity 3182 | SaleCommon Stock | 7,000 | $85.00 | $595,000.00 |
DisclosureSEC source: 0001209191-23-005452 · doc4.xml · nonDerivative · entry 2 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,835 F1 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. F2 · balance_after: Includes an aggregate of 40,178 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. Read SEC document |
| January 26, 2023 Filed Jan 30, 2023 21:00 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionCommon Stock | 7,000 | $68.62 | $480,340.00 |
DisclosureSEC source: 0001209191-23-005452 · doc4.xml · nonDerivative · entry 1 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,835 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 20, 2023 Filed Jan 24, 2023 21:01 UTC | INCYTE CORP INCY · Entity 3182 | GrantEmployee Stock Option (right to buy) · Derivative | 14,194 | $0.00 Strike: $83.20 | $0.00 |
DisclosureSEC source: 0001209191-23-004569 · doc4.xml · derivative · entry 2 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,194 Underlying: Common Stock · 14,194 shares Expires 2033-01-19 F3 · derivative.exercise_date: Beginning January 20, 2023, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2023 and the remainder vesting monthly over three years. Read SEC document |
| January 20, 2023 Filed Jan 24, 2023 21:01 UTC | INCYTE CORP INCY · Entity 3182 | GrantCommon Stock | 4,980 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-004569 · doc4.xml · nonDerivative · entry 1 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,835 F1 · shares: Represents shares of common stock underlying performance shares earned upon the achievement of performance criteria determined to be satisfied on January 20, 2023. The earned shares will vest on the third anniversary of the July 2, 2020 grant date, subject to the Reporting Persons continued service with the Issuer. Each performance share represents the right to receive one or more shares of common stock based on, and subject to, the achievement of specified financial and development performance criteria determined by the Issuers Compensation Committee in January 2020 as set forth in the Performance Share Award Agreement. The number of shares of common stock that the Reporting Person is entitled to receive over the three year performance period ranges from 0% to 175% of the number of performance shares awarded. F2 · balance_after: This includes an aggregate of 40,178 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. The aggregate amount also includes the additional Performance Stock Units earned on January 20, 2023. Read SEC document |
| December 23, 2022 Filed Dec 28, 2022 21:00 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $68.62 | $0.00 |
DisclosureSEC source: 0001209191-22-062808 · doc4.xml · derivative · entry 8 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,000 shares Expires 2028-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Beginning July 2, 2018, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2019 and the remainder vesting monthly over three years. Read SEC document |
| December 23, 2022 Filed Dec 28, 2022 21:00 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 7,866 | $0.00 Strike: $72.86 | $0.00 |
DisclosureSEC source: 0001209191-22-062808 · doc4.xml · derivative · entry 7 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,866 shares Expires 2023-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Beginning May 9, 2016, options become exercisable in 25 installments, with the first 33.33% vesting on May 9, 2017 and the remainder vesting monthly over two years. Read SEC document |
| December 23, 2022 Filed Dec 28, 2022 21:00 UTC | INCYTE CORP INCY · Entity 3182 | SaleCommon Stock | 1,654 | $80.79 | $133,626.66 |
DisclosureSEC source: 0001209191-22-062808 · doc4.xml · nonDerivative · entry 6 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,855 F1 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. F2 · balance_after: Includes an aggregate of 35,198 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. Read SEC document |
| December 23, 2022 Filed Dec 28, 2022 21:00 UTC | INCYTE CORP INCY · Entity 3182 | SaleCommon Stock | 804 | $80.77 | $64,939.08 |
DisclosureSEC source: 0001209191-22-062808 · doc4.xml · nonDerivative · entry 5 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,509 F1 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. Read SEC document |
| December 23, 2022 Filed Dec 28, 2022 21:00 UTC | INCYTE CORP INCY · Entity 3182 | SaleCommon Stock | 7,000 | $80.80 | $565,600.00 |
DisclosureSEC source: 0001209191-22-062808 · doc4.xml · nonDerivative · entry 4 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,313 F1 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. Read SEC document |
| December 23, 2022 Filed Dec 28, 2022 21:00 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionCommon Stock | 7,000 | $68.62 | $480,340.00 |
DisclosureSEC source: 0001209191-22-062808 · doc4.xml · nonDerivative · entry 3 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,313 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 23, 2022 Filed Dec 28, 2022 21:00 UTC | INCYTE CORP INCY · Entity 3182 | SaleCommon Stock | 7,866 | $80.80 | $635,572.80 |
DisclosureSEC source: 0001209191-22-062808 · doc4.xml · nonDerivative · entry 2 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,313 F1 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. Read SEC document |
| December 23, 2022 Filed Dec 28, 2022 21:00 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionCommon Stock | 7,866 | $72.86 | $573,116.76 |
DisclosureSEC source: 0001209191-22-062808 · doc4.xml · nonDerivative · entry 1 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,179 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 07, 2022 Filed Jul 11, 2022 20:00 UTC | INCYTE CORP INCY · Entity 3182 | SaleCommon Stock | 5,787 | $79.38 | $459,372.06 |
DisclosureSEC source: 0001209191-22-041762 · doc4.xml · nonDerivative · entry 1 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,313 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. F2 · balance_after: Includes an aggregate of 25,277 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. Read SEC document |
| July 05, 2022 Filed Jul 6, 2022 20:08 UTC | INCYTE CORP INCY · Entity 3182 | Tax withholdingCommon Stock | 2,599 | $79.25 | $205,970.75 |
DisclosureSEC source: 0001209191-22-041074 · doc4.xml · nonDerivative · entry 2 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,100 F2 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of RSUs or earned performance shares previously reported in Table I as common stock. F3 · balance_after: Including the July 2, 2022 RSU Grant, this includes an aggregate of 25,277 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not vested. Read SEC document |
| July 02, 2022 Filed Jul 6, 2022 20:08 UTC | INCYTE CORP INCY · Entity 3182 | GrantEmployee Stock Option (right to buy) · Derivative | 13,443 | $0.00 Strike: $77.67 | $0.00 |
DisclosureSEC source: 0001209191-22-041074 · doc4.xml · derivative · entry 3 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,443 Underlying: Common Stock · 13,443 shares Expires 2032-07-01 F4 · derivative.exercise_date: Beginning July 2, 2022, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Read SEC document |
| July 02, 2022 Filed Jul 6, 2022 20:08 UTC | INCYTE CORP INCY · Entity 3182 | GrantCommon Stock | 9,921 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-041074 · doc4.xml · nonDerivative · entry 1 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,699 F1 · shares: Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years, subject to Vijay Iyengar's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis. Read SEC document |
| January 19, 2022 Filed Jan 21, 2022 21:18 UTC | INCYTE CORP INCY · Entity 3182 | GrantEmployee Stock Option (right to buy) · Derivative | 15,054 | $0.00 Strike: $74.78 | $0.00 |
DisclosureSEC source: 0001209191-22-004417 · doc4.xml · derivative · entry 1 Iyengar Vijay K · CIK 0001670000 · EVP GPS, BD, & Licensing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,054 Underlying: Common Stock · 15,054 shares Expires 2032-01-18 F1 · derivative.exercise_date: Beginning January 19, 2022, options become exercisable in 37 installments, with the first 25.00% vesting on July 2, 2022 and the remainder vesting monthly over three years. Read SEC document |
| January 01, 2022 Filed Jan 5, 2022 21:12 UTC | INCYTE CORP INCY · Entity 3182 | GrantCommon Stock | 8,678 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-001643 · doc4.xml · nonDerivative · entry 1 Iyengar Vijay K · CIK 0001670000 · EVP GPS, BD, & Licensing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,417 F1 · shares: Represents award of restricted stock units ("RSUs") that will vest 100% on December 31, 2025, subject to Vijay Iyengar's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis. F2 · balance_after: Includes an aggregate of 33,663 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Read SEC document |
| November 19, 2021 Filed Nov 23, 2021 21:16 UTC | INCYTE CORP INCY · Entity 3182 | GrantCommon Stock | 2,355 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-066409 · doc4.xml · nonDerivative · entry 2 Iyengar Vijay K · CIK 0001670000 · EVP GPS, BD, & Licensing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,739 F2 · shares: Represents shares of common stock underlying performance shares earned upon the interim achievement of performance criteria determined to be satisfied on November 19, 2021. The earned shares will vest on the third anniversary of the July 2, 2021 grant date, subject to the Reporting Persons continued service with the Issuer. Each performance share represents the right to receive one or more shares of common stock based on, and subject to, the achievement of specified financial and development performance criteria determined by the Issuers Compensation Committee in February 2021 as set forth in the Performance Share Award Agreement. The number of shares of common stock that the Reporting Person is entitled to receive over the three year performance period ranges from 0% to 150% of the number of performance shares awarded. F3 · balance_after: Including the Performance Stock Units earned on November 19, 2021, this includes an aggregate of 24,985 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. Read SEC document |
| November 19, 2021 Filed Nov 23, 2021 21:16 UTC | INCYTE CORP INCY · Entity 3182 | GrantCommon Stock | 379 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-066409 · doc4.xml · nonDerivative · entry 1 Iyengar Vijay K · CIK 0001670000 · EVP GPS, BD, & Licensing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,384 F1 · shares: Represents shares of common stock underlying performance shares earned upon the interim achievement of performance criteria determined to be satisfied on November 19, 2021. The earned shares will vest on the third anniversary of the July 2, 2020 grant date, subject to the Reporting Persons continued service with the Issuer. Each performance share represents the right to receive one or more shares of common stock based on, and subject to, the achievement of specified financial and development performance criteria determined by the Issuers Compensation Committee in January 2020 as set forth in the Performance Share Award Agreement. The number of shares of common stock that the Reporting Person is entitled to receive over the three year performance period ranges from 0% to 175% of the number of performance shares awarded. Read SEC document |
| July 29, 2021 Filed Aug 2, 2021 20:14 UTC | INCYTE CORP INCY · Entity 3182 | SaleCommon Stock | 4,911 | $78.29 | $384,482.19 |
DisclosureSEC source: 0001209191-21-049063 · doc4.xml · nonDerivative · entry 1 Iyengar Vijay K · CIK 0001670000 · EVP GPS, BD, & Licensing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,005 F1 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. F2 · price: Represents weighted average sale price. Actual sale prices ranged from $77.99 - $78.56. F3 · price: Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated. F4 · balance_after: This includes an aggregate of 22,251 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested. Read SEC document |
| July 06, 2021 Filed Jul 7, 2021 20:28 UTC | INCYTE CORP INCY · Entity 3182 | Tax withholdingCommon Stock | 401 | $83.34 | $33,419.34 |
DisclosureSEC source: 0001209191-21-045800 · doc4.xml · nonDerivative · entry 3 Iyengar Vijay K · CIK 0001670000 · EVP GPS, BD, & Licensing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,916 F2 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units or earned performance shares previously reported in Table I as common stock. F3 · balance_after: Including the July 2, 2021 Restricted Stock Unit Grant, this includes an aggregate of 22,251 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.